Álvaro M.
- Country
- Portugal
- Department
- Centro Clínico Académico - Braga
Research Overview
- Oral semaglutide versus placebo in early Alzheimer’s disease: a randomized double-blind trial in patients with mild cognitive impairment or mild dementia
- Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of AVP‑786 (deudextromethorphan hydrobromide/quinidine) for Agitation in Alzheimer’s Dementia
- Evaluation of the Safety and Efficacy of Subcutaneous Tertomotide (GV1001) in Mild to Moderate Alzheimer's Disease: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 99 of 173 partner sites.
Specializations
Early-Stage Alzheimer's Research
The investigator specializes in studying therapeutic interventions for early-stage Alzheimer's disease, with particular focus on mild cognitive impairment (MCI) and mild dementia. Their research encompasses innovative approaches using both oral medications and intravenous treatments targeting amyloid reduction.
- Cognitive Function Assessment
- Disease Progression Monitoring
- Early Intervention Strategies
Neurodegenerative Disorders
The investigator conducts research in various neurodegenerative conditions, including Frontotemporal Dementia (FTD). Their work extends to investigating novel therapeutic compounds for different forms of dementia, with emphasis on understanding disease mechanisms and potential treatments.
- FTD-Specific Therapies
- Long-term Safety Studies
- Neurological Assessment
Behavioral Symptoms Management
Their expertise includes managing behavioral manifestations in dementia, particularly focusing on agitation in Alzheimer's type dementia. The investigator evaluates novel therapeutic approaches for behavioral symptom control and patient quality of life improvement.
- Agitation Treatment
- Behavioral Assessment
- Symptom Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.